Zobrazeno 1 - 10
of 34
pro vyhledávání: '"W. B. Nowell"'
Autor:
William N Malatestinic, W. B. Nowell, Jeffrey R. Curtis, Carol Himelein, Rebecca Bolce, Jessica A. Walsh, Jeffrey R. Lisse, Theresa Hunter, K. Gavigan
Publikováno v:
ACR Open Rheumatology
ACR Open Rheumatology, Vol 4, Iss 1, Pp 85-94 (2022)
ACR Open Rheumatology, Vol 4, Iss 1, Pp 85-94 (2022)
Objective Aims were to 1) to characterize patient decision-making with treatment for axial spondyloarthritis (axSpA) and 2) to explore relationships among decision-making, treatment satisfaction, and biologic disease modifying antirheumatic drugs (bD
Publikováno v:
Inflammatory Bowel Diseases. 28:983-987
Background The current burden of Crohn’s disease (CD) and ulcerative colitis (UC) in minority populations is largely unknown. We sought to evaluate the relative prevalence of CD and UC across racial and ethnic groups within the National Patient-Cen
Autor:
George Munoz, Howard Busch, Jeffrey R. Curtis, Fenglong Xie, William Sunshine, Patrick Stewart, Shubhasree Banerjee, Daniel Kirby, Shilpa Venkatachalam, David Curtis, Peter A. Merkel, K. Gavigan, Michael D. George, Joshua F. Baker, W. B. Nowell, Maria I. Danila
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 6, Pp 381-389 (2021)
ACR Open Rheumatology
ACR Open Rheumatology
BACKGROUND: We aimed to compare concerns, social distancing, health care disruptions, and telemedicine use in patients with autoimmune rheumatic disease (ARD) and non-ARD and to evaluate factors associated with immunomodulatory medication interruptio
Autor:
Ellen Peters, Liana Fraenkel, Shilpa Venkatachalam, Christine E. Stake, W. B. Nowell, Erik Harden, Thomas W Concannon
Publikováno v:
Journal of Comparative Effectiveness Research. 9:1153-1166
Aim: Research regarding decisions patients make about total knee arthroplasty, apart from having the procedure or not, are limited. Understanding patient decision making and related information needs is essential for shared decision making. Methods:
Autor:
W. B. Nowell, K. Gavigan, K. Garza, A. Ogdie, M. George, J. A. Walsh, M. Danila, S. Venkatachalam, L. Stradford, J. Curtis
Publikováno v:
Annals of the Rheumatic Diseases. 81:1128-1129
BackgroundGenerating information that people living with a rheumatic and musculoskeletal disease (RMD) find useful while making decisions about their treatment requires identifying and understanding educational needs and interests directly expressed
Publikováno v:
Annals of the Rheumatic Diseases. 81:265-266
BackgroundThe COVID-19 pandemic causes concern among patients with autoimmune and rheumatic disease (ARD) due to increased risk of infection and heightened isolation from social distancing.1ObjectivesExamine how mean patient-reported outcome (PRO) sc
Autor:
B. Hsiao, J. Downs, M. Lanyon, J. R. Curtis, S. Blalock, C. Wiedmeyer, S. Venkatachalam, W. B. Nowell, L. Fraenkel
Publikováno v:
Annals of the Rheumatic Diseases. 81:1890.2-1891
BackgroundUptake of treat to target strategies for the management of rheumatoid arthritis (RA) is low. System-related barriers to accessing treatment are known, but poor adherence to starting and continuing treatment are prevalent causes of suboptima
Autor:
D. Hernandez, J. Bravo, J. J. Maya, O. Soto-Raíces, A. Tapia, G. Valenzuela, W. B. Nowell, S. Venkatachalam
Publikováno v:
Annals of the Rheumatic Diseases. 81:1891.2-1891
BackgroundNonlinear associations in rheumatoid arthritis (RA) prevalence and sociodemographic indices suggest social determinants of health affect RA.1 RA screening tools have lower sensitivity and specificity for Hispanic/Latinx individuals compared
Autor:
Carol L Kannowski, W. B. Nowell, Jennifer Workman, K. Gavigan, Julie Birt, Anabela Cardoso, Tariq Daud, Theresa Hunter, Zhihong Cai, Jeffrey R. Curtis
Publikováno v:
Rheumatology. 59
Background Little is known about PRO measures patients find most important for disease, treatment effectiveness/health outcomes. In this study, we examined PROs selected by patients with rheumatologic conditions to further elucidate which disease sym
Autor:
W. B. Nowell, Tony Hunter, Jessica A. Walsh, Rebecca Bolce, William N Malatestinic, Jeffrey R. Curtis, Jeffrey R. Lisse, C. Himelein, K. Gavigan
Publikováno v:
Annals of the Rheumatic Diseases. 80:1034-1035
Background:Biologic disease-modifying antirheumatic drug (bDMARD) therapy has been shown to be effective in the treatment of axial spondyloarthritis (axSpA).1,2 Little is understood about patients’ experience of axSpA treatment from their own persp